The no-marijuana (marijuana) -based drug will soon be available in the US for the treatment of extreme epilepsy in children. Epidiolex, a British pharmaceutical production company, uses the basic ingredients of pure cannabidiol. The US Federal Food and Drug Service, FDA, approved Monday the marketing of Epidiolex, which is made by the British pharmaceutical company GW Pharmaceuticals. A psychoactive ingredient that can get people drunk marijuana. When experimenting with other drugs, Epidiolex proved to be more effective in reducing the frequency of seizures in epilepsy attacks than other drugs or placebo. Perhaps, you are considering the one with no thc for the number of reasons.
It is important to note that this is not an agreement (consumption) of cannabis or all its components. This is an agreement for one specific CBD-based drug for special use. And it is based on well-controlled clinical trials that evaluate the use of these compounds in the treatment of certain conditions. Both forms of epilepsy cause severe seizures in children. The agreement was issued after a number of cases of severe epilepsy in children were highlighted in the UK. After great public pressure, the British Interior Minister finally allowed a 12-year-old child to be treated with a set of drugs that were still banned in England which was confiscated from the child’s mother when he returned from Canada to England.
Before Epidiolex was marketed, approval was still needed from the US drug control agency DEA. The agency divides narcotics into five categories based on potential abuse. Category 1 narcotics such as marijuana and heroin are considered the most dangerous and are considered to have no medical benefits at all. DEA decisions are expected to be made in 90 days. Up to 30 US states have now enabled the use of marijuana for medical purposes in several forms. The Epidiolex approval by the FDA came a week after Canada legalized the use of marijuana for recreational purposes.